Guggenheim Maintains Buy on Pharvaris, Raises Price Target to $39

Benzinga · 1d ago
Guggenheim analyst Debjit Chattopadhyay maintains Pharvaris (NASDAQ:PHVS) with a Buy and raises the price target from $32 to $39.